Table 3.
Discovery meta-analysis | Replication: age 7–9 years | Replication: age 16 years | ||||||
---|---|---|---|---|---|---|---|---|
Prenatal newborn methylation | BAMSE () | HELIX () | BAMSE () | |||||
Chr | Positionb | CpG | Genec | (P-value) | Directiond | (P-value) | (P-value) | (P-value) |
7 | 132192823 | cg16811875 | PLXNA4 | (2.67E-08) | (0.41) | (0.19) | 0.0001 (0.86) | |
12 | 8324628 | cg12193649 | ZNF705A | (1.37E-07) | XXXX | X | (0.76) | X |
14 | 104376135 | cg11886880 | down C14orf2 | (1.81E-07) | X | (0.78) | (0.11) | 0.0002 (0.50) |
5 | 131132836 | cg16253537 | FNIP1 | 0.001 (4.10E-07) | (0.37) | 0.00008 (0.43) | 0.0001 (0.63) | |
8 | 139890342 | cg12044654 | COL22A1 | (6.42E-07) | 0.0004 (0.46) | (0.07) | 0.0001 (0.67) | |
13 | 114165365 | cg19120073 | TMCO3 | (7.77E-07) | (0.87) | (0.39) | (0.23) | |
12 | 132239000 | cg05479174 | SFRS8 | (7.99E-07) | 0.0002 (0.87) | (0.93) | 0.0005 (0.44) | |
5 | 134879739 | cg06846669 | up NEUROG1 | (8.92E-07) | (0.59) | 0.00007 (0.77) | (0.88) | |
19 | 13875381 | cg23270359 | MRI1 | (9.43E-07) | (0.84) | 0.00035 (0.01) | (0.71) | |
19 | 43690622 | cg01011943 | PSG5 | 0.003 (1.05E-06) | XXXX | X | (0.93) | X |
7 | 1177965 | cg00348551 | C7orf50 | 0.001 (1.13E-06) | XXXX | 0.0008 (0.13) | 0.00010 (0.51) | (0.32) |
1 | 2251570 | cg24709511 | down MORN1 | (1.57E-06) | (0.50) | (0.30) | 0.0004 (0.23) | |
8 | 42064673 | cg22038738 | PLAT | (1.61E-06) | 0.0008 (0.39) | (0.51) | 0.0006 (0.32) | |
1 | 247169036 | cg02236896 | ZNF695 | (2.05E-06) | X | (0.34) | (0.24) | (0.64) |
Note: , coefficient for methylation with an IQR increase in prenatal exposure; CHR, chromosome.
Discovery meta-analysis does not include the Generation R cohort due to missing prenatal data.
Chromosomal position based on NCBI human reference genome assembly Build 37.
UCSC annotated gene.
Direction of methylation for each cohort included in the analysis (INMA, Project Viva, CHS, PRISM, ENVIRONAGE, Rhea, Piccolipiù, EARLI): , , .